Nascent Pharma Holdings, Inc.(NASC.US)

Company Encyclopedia

Nascent Pharma Holdings, Inc.

NASC.US

Nascent Pharma Holdings, Inc. engages in the protection and commercialization of cannabis patents. It produces superfood drink mix products under the Longevity brand name. The company was formerly known as Can B Corp.

4.992 T

NASC.USMarket value -Rank by Market Cap -/-

Valuation analysis

P/E

10Y

P/E

Industry Ranking

-/-

P/E
Price
High
Median
Low

P/B

10Y

P/B

Industry Ranking

-/-

P/B
Price
High
Median
Low

P/S

10Y

P/S

Industry Ranking

-/-

P/S
Price
High
Median
Low

Dividend Yield

10Y

Dividend Yield

Industry Ranking

-/-

Dividend Yield
Price
High
Median
Low

Institutional View & Shareholder

Analyst Ratings

Rating

Percentage

Price
--
Highest
--
Lowest
--

Shareholder

Ownership	%Owned	Share Chg	Report Date
Arena Investors, LP	0.16%	No Change	30/09/2024

News

17:31 ET Gastroesophageal Reflux Disease Market in the US to Show Promising Growth at a CAGR of 6% During the Forecast Period (2025-2034) | DelveInsight

The gastroesophageal reflux disease (GERD) market in the US is projected to grow at a CAGR of 6% from 2025 to 2034, driven by rising prevalence and new therapies. The market size was USD 3.3 billion in 2024, with approximately 33 million diagnosed cases. Key players like Braintree Laboratories and Cinclus Pharma are developing next-generation treatments, including BLI5100 and linaprazan glurate, to address unmet needs. VOQUEZNA, the first approved potassium-competitive acid blocker (PCAB), is expected to dominate the market due to its superior efficacy compared to traditional PPIs.

prnewswire·01/23/2026 06:32